Issue #106 "Pulmonary & Nasal Delivery" is out now and available online! Read it here: https://t.co/D7eEagZhkM
We're proud of this edition - despite adverse circumstances it's the biggest, most strongly supported respiratory issue we've ever published. Enjoy! #drugdelivery
New Clinical Trial Results Continue to Demonstrate Inhibition of Platelet Aggregation in Two Minutes With Dry Powder Inhalation of Aspirin Formulation for High Risk Patients to Treat Suspected Acute MI #respiratory#aspirin https://t.co/rCf6cXokgD
OTITOPIC™ New Clinical Trial Results Continue to Demonstrate Inhibition of Platelet Aggregation in Two Minutes With Dry Powder Inhalation of Aspirin Formulation for High Risk Patients to Treat Suspected Acute Myocardial Infarction (MI) | Business Wire https://t.co/pSNR4IeDHJ
We have just published our November issue (#102) focusing from cover-to-cover on "Pulmonary & Nasal Delivery". Click here to read it now! https://t.co/0Cwzzqx5ZM
An important reminder for every entrepreneur: stay focused and be patient. Read more advice from @andrew__reed in this week’s #SevenQuestions newsletter.